Literature DB >> 24631029

Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.

Valentina Giorgio1, Luca Miele2, Luigi Principessa3, Francesca Ferretti1, Maria Pia Villa3, Valentina Negro3, Antonio Grieco4, Anna Alisi1, Valerio Nobili5.   

Abstract

BACKGROUND: Increased intestinal permeability seems to play a major role in non-alcoholic liver disease development and progression. AIM: To investigate the prevalence of altered intestinal permeability in children with non-alcoholic fatty liver disease, and to study its potential association with the stage of liver disease.
METHODS: We performed a case-control study examining intestinal permeability in children using the lactulose-mannitol bowel permeability test.
RESULTS: Overall, 39 consecutive patients (30 males, median age 12 years) and 21 controls (14 males, median age 11.8 years) were included. The lactulose/mannitol ratio resulted impaired in 12/39 patients (31%) and none of the controls. Intestinal permeability was higher in children with non-alcoholic fatty liver disease (lactulose/mannitol ratios: 0.038±0.037 vs. 0.008±0.007, p<0.05). Within the non-alcoholic fatty liver disease group, intestinal permeability was increased in children with steatohepatitis compared to those with steatosis only (0.05±0.04 vs. 0.03 vs. 0.03, p<0.05). Pathological lactulose/mannitol ratio correlated with portal inflammation (p=0.02), fibrosis (p=0.0002), and ballooning of hepatocytes (p=0.003). Blood lipopolysaccharides levels were higher in children with steatohepatitis (2.27±0.68 vs. 2.80±0.35, p<0.05).
CONCLUSIONS: Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with the severity of the disease.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intestinal permeability; Lactulose/mannitol ratio; Lipopolysaccharides; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis

Mesh:

Substances:

Year:  2014        PMID: 24631029     DOI: 10.1016/j.dld.2014.02.010

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  59 in total

1.  Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome.

Authors:  Luca Miele; Giovanni Gasbarrini; Valentina Giorgio; Antonio Gasbarrini; Antonio Grieco
Journal:  Intern Emerg Med       Date:  2015-11-24       Impact factor: 3.397

Review 2.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 3.  Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

Authors:  Giulia Paolella; Claudia Mandato; Luca Pierri; Marco Poeta; Martina Di Stasi; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.

Authors:  Gabriella V Hernandez; Victoria A Smith; Megan Melnyk; Matthew A Burd; Kimberly A Sprayberry; Mark S Edwards; Daniel G Peterson; Darin C Bennet; Rob K Fanter; Daniel A Columbus; Juan P Steibel; Hunter Glanz; Chad Immoos; Margaret S Rice; Tasha M Santiago-Rodriguez; Jason Blank; Jennifer J VanderKelen; Christopher L Kitts; Brian D Piccolo; Michael R La Frano; Douglas G Burrin; Magdalena Maj; Rodrigo Manjarin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

Review 5.  Gut Microbiota of Nonalcoholic Fatty Liver Disease.

Authors:  Reham M Abdou; Lixin Zhu; Robert D Baker; Susan S Baker
Journal:  Dig Dis Sci       Date:  2016-02-22       Impact factor: 3.199

Review 6.  Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.

Authors:  Rotonya M Carr; Amanke Oranu; Vandana Khungar
Journal:  Gastroenterol Clin North Am       Date:  2016-10-13       Impact factor: 3.806

7.  Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Enea Bonci; Lidia Marandola; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 8.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

9.  Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shanshan Jin; Suwen Jiang; Airong Hu
Journal:  Sleep Breath       Date:  2018-01-15       Impact factor: 2.816

10.  Assessment of the Intestinal Barrier with Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice.

Authors:  Valentina Volynets; Astrid Reichold; Gyöngyi Bárdos; Andreas Rings; André Bleich; Stephan C Bischoff
Journal:  Dig Dis Sci       Date:  2015-10-31       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.